What is the Trelegy Ellipta?

Trelegy Ellipta is a medication that combines three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. It is primarily used as a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults. Fluticasone furoate is an inhaled corticosteroid that helps reduce inflammation in the airways. Umeclidinium is a long-acting muscarinic antagonist that helps relax the muscles around the airways, improving breathing. Vilanterol is a long-acting beta2-adrenergic agonist that helps open up the airways, allowing for easier breathing. Trelegy Ellipta is administered through an inhaler device and is taken once daily. It is important to follow the prescribed dosage and consult a healthcare professional for proper usage instructions.

Trelegy Ellipta
Trelegy Ellipta
Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate
Select product strength & quantity:
Select product strength & quantity:

Prescription Required.

Product of Canada.

Shipped from Canada.

Prescription Required.Product of Canada.Shipped from Canada.

What is the Trelegy Ellipta?

TRELEGY ELLIPTA is a combination of prescription corticosteroid, anticholinergic, and long-acting beta2-adrenergic agonist inhaled into the lungs to treat chronic obstructive pulmonary disease. It is manufactured as TRELEGY ELLIPTA 100/62.5/25, a combination of fluticasone furoate 100 mcg, umeclidinium 62.5 mcg, and vilanterol 25 mcg.

People who take TRELEGY ELLIPTA have an increased risk of death from asthma-related problems. This is because it contains vilanterol, a long-acting beta2-adrenergic agonist. Therefore, it is essential to contact your healthcare provider if you experience worsening breathing while using TRELEGY ELLIPTA. You should seek urgent medical care if you have rapid worsening of your breathing, and your rescue inhaler does not help to relieve these symptoms.

TRELEGY ELLIPTA is not approved for treating asthma.

Using TRELEGY ELLIPTA increases the risk of death from asthma problems.

TRELEGY ELLIPTA is a combination of prescription corticosteroid, anticholinergic, and long-acting beta2-adrenergic agonist inhaled into the lungs to treat chronic obstructive lung disease. It is manufactured as TRELEGY ELLIPTA 100/62.5/25, a combination of fluticasone furoate 100 mcg, umeclidinium 62.5 mcg, and vilanterol 25 mcg.

The dose of TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease is one inhalation of the fluticasone furoate 100 mcg, umeclidinium 62.5 mcg, and vilanterol 25 mcg combination, taken once a day.

TRELEGY ELLIPTA comes in a sealed foil tray. To open the tray, peel back the lid. Each inhaler can dispense 30 doses. When you open the inhaler cover, you will hear a clicking sound, and the dose counter will decrease by one. Opening the cover primes the inhaler for delivery. Do not close the cover without inhaling the medication or you will lose the prepared dose. You cannot take a double dose because the prepared dose will become unavailable once you close the cover.

To inhale the dose, slide the cover down so that you can see the mouthpiece. You will hear a click, and the counter will go down by one number. You do not need to shake this inhaler. Hold the inhaler away from your mouth and breathe out completely. Make sure that you do not breathe out into the mouthpiece. Now place the mouthpiece between your lips and take a long deep breath in through your mouth. Make sure that you do not breathe in through your nose. Also, ensure that your hands do not block the air vent on the inhaler. Hold your breath for three to four seconds after you have inhaled. When breathing in the powder, you may not taste or feel it. This does not mean that you have not received a dose. Once you have taken the required dose, close the inhaler by sliding the cover back into position.

It is important to rinse your mouth out once you have inhaled your dose. This is to prevent you from developing thrush in your mouth and throat. Make sure that you do not swallow the water.

TRELEGY ELLIPTA is contraindicated in patients with a hypersensitivity to milk proteins, fluticasone furoate, umeclidinium, or vilanterol.

TRELEGY ELLIPTA is also contraindicated in patients with status asthmaticus or patients with acute exacerbations of chronic obstructive pulmonary disease who may be requiring intensive management measures.

If you miss a dose of TRELEGY ELLIPTA, try to take it as soon as possible, then continue with the usual medication schedule. However, if you are due to take your next dose, skip the dose you missed and continue with your regular medication schedule. Under no circumstances should you take a double dose of the medication to make up for the missed dose. If you are unsure about what to do, contact your doctor or local pharmacist to obtain advice.

Common side effects of TRELEGY ELLIPTA include:

  • Thrush in the mouth and throat (Candida albicans)
  • Sinusitis
  • Headaches
  • Back pain
  • Fever
  • Chest infection
  • Changes in voice
  • Changes in taste
  • Difficulty sleeping
  • Nausea, vomiting and diarrhea
  • Cough
  • Mouth and throat pain

Less common side effects include:

  • Pneumonia
  • Bronchitis
  • Suppression of the immune system
  • Reduction in bone density
  • Glaucoma and cataracts
  • Systemic eosinophilia
  • Churg-Strauss syndrome
  • Anaphylaxis
  • Sudden breathing problems after inhaling the medication
  • Effects on the heart, like increased blood pressure, chest pain, or a fast heartbeat
  • Tremors or shakes
  • Inability to pass urine, or pain when trying to pass urine
  • Development of high blood sugar levels and low levels of potassium

Some side effects can be severe and require medical attention. Contact your doctor immediately if you notice any of the following:

  • worsening of your asthma
    • difficulty breathing
    • shortness of breath
    • tight chest
  • changes in your vision
  • swelling of your face with a skin rash
  • acute confusion or aggression
  • development of a temperature or other signs of an infection

If you experience severe side effects, immediately contact your doctor, or go to the nearest emergency health care facility.

TRELEGY ELLIPTA should be stored away from children. It should be stored in a dry place at room temperature, away from heat and sunlight. It should be stored unopened in its foil pouch and only opened when ready for use.